Literature DB >> 3966605

Contraceptive usage during lactation: analysis of 1973 and 1976 National Survey of Family Growth: I. Age and race.

M Labbok, K Ford, R H Gray.   

Abstract

Data from the National Survey of Family Growth are analyzed to estimate the prevalence of contraceptive use during lactation. Approximately 20 per cent of lactating women were sexually active and did not use a method in months two through six, postpartum. Among method users, the largest proportion chose barrier methods but 14 per cent used oral contraceptives in the early postpartum period. Between 1973 and 1976 there was an increase in the percentage of women who utilized a contraceptive method during lactation and a decrease in the per cent using oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966605      PMCID: PMC1646131          DOI: 10.2105/ajph.75.1.75

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Transfer of contraceptive steroids to human milk.

Authors:  S Nilsson; K G Nygren
Journal:  Res Reprod       Date:  1979-01

2.  1980 update: the recent trend in breast-feeding.

Authors:  G A Martinez; J P Nalezienski
Journal:  Pediatrics       Date:  1981-02       Impact factor: 7.124

3.  Oral contraceptive during lactation: a global survey of physician practice.

Authors:  L T Strauss; M Speckhard; R W Rochat; P Senanayake
Journal:  Int J Gynaecol Obstet       Date:  1981-06       Impact factor: 3.561

4.  Decisions on breast-feeding or formula feeding and trends in infant-feeding practices.

Authors:  H P Sarett; K R Bain; J C O'Leary
Journal:  Am J Dis Child       Date:  1983-08

5.  Trends and differentials in breast feeding: an update.

Authors:  C Hirschman; M Butler
Journal:  Demography       Date:  1981-02
  5 in total
  1 in total

1.  Drug utilization in breast-feeding women. A survey in Oslo.

Authors:  I Matheson; K Kristensen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.